-
Integrase Inhibitors -- Recent Developments in ART: An Expert Interview With Dr. Martin Markowitz From The New York Course
In this Expert Interview, Dr. Martin Markowitz is interviewed by Dr. Eric Daar on the specifics of his presentation at The New York Course regarding integrase inhibitors and their new role in ART.
Expert Interview, May 2008
-
CME
Incorporating Integrase Inhibitors into Clinical Practice
Drs. Martin Markowitz, Eric S. Daar, and Jurgen Rockstroh discuss the newest class of antiretrovirals to join the HIV armamentarium, the integrase inhibitor class.
Roundtable, March 2008
-
Metabolic Comorbidities and Antiretroviral Therapy: An Expert Interview From CROI 2008 With Simon A. Mallal, MBBS, FRACP, FRCPA
Dr. Simon A. Mallal discusses the latest data from CROI 2008 in regard to the metabolic comorbidities associated with HIV infection and antiretroviral therapy.
Expert Interview, March 2008
-
Highlights From the 15th Conference on Retroviruses and Opportunistic Infections: An Expert Interview With John G. Bartlett, MD
Read Dr. Bartlett's impressions of the most significant research presented at CROI 2008, including data on metabolic complications, prevention strategies, OIs and coinfections, and the newest ART.
Expert Interview, February 2008
-
Literature Commentary by Dr. John G. Bartlett: Osteonecrosis in HIV+ Patients, January 2008
In this review and commentary: A study of the incidence of symptomatic and asymptomatic osteonecrosis using magnetic resonance imaging (MRI) reveals a need for improved prevention and treatment.
Commentary, January 2008
-
Literature Commentary by Dr. John G. Bartlett: HIV Prevention, January 2008
In this review and commentary: Two randomized clinical trials to evaluate whether latex diaphragms or tenofovir preexposure prophylaxis reduce HIV transmission in women.
Commentary, January 2008
-
Literature Commentary by Dr. John G. Bartlett: HIV Antiretroviral Resistance, January 2008
In this review and commentary: review of recent results in HIV resistance, including effects of partially suppressive regimens and the importance of adherence to antiretroviral therapy.
Commentary, January 2008
-
Literature Commentary by Dr. John G. Bartlett: Nevirapine Pharmacokinetics, January 2008
In this review and commentary: a study of nevirapine (NVP) levels after discontinuation supports continuation of NRTIs for 7 to 10 days after stopping NVP.
Commentary, January 2008
-
Literature Commentary by Dr. John G. Bartlett: Treatment of Cryptococcal Meningitis in HIV, January 2008
In this review and commentary: Clinical trial of amphotericin B vs fluconazole in ART-naive or ART-experienced patients in South Africa.
Commentary, January 2008
-
Literature Commentary by Dr. John G. Bartlett: CD4+ Count Normalization With HAART, January 2008
In this review and commentary: CD4+ cell count increases continue over 5 years of follow-up with HIV RNA less than 50 copies/mL on HAART.
Commentary, January 2008
